Sexual Dysfunction in Partner of Patients With Ankylosing Spondylitis

NCT ID: NCT04411485

Last Updated: 2020-06-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-02-15

Study Completion Date

2020-07-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The adverse effects of rheumatologic diseases, especially Ankylosing Spondylitis (AS), on sexual functions are known. The causes of sexual dysfunction in rheumatologic diseases are due to factors such as pain, weakness, fatigue, stiffness, functional disability, anxiety, depression, hormonal deficiency, drug use, decreased libido and poor body image. Depending on these factors, sexual intercourse and frequency of sexual intercourse may decrease. Sexual dysfunction may be seen in AS due to physical and emotional problems caused by the disease.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

There are many studies in the literature that determine sexual satisfaction and sexual dysfunction in individuals with AS and compare individuals with AS to healthy individuals . In the light of these studies, the investigators thought that the sexual function of partner of individuals with AS may also be affected negatively. In the literature, no previous study examines the sexual function of partner of individuals with AS. Therefore, the aim was to determine the sexual function of partner of individuals with AS and to compare with healthly adults of the same sex.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ankylosing Spondylitis Sexual Dysfunction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group of Ankylosing Spondylitis

Patient with ankylosing spondylitis diagnosed by a rheumatologist

Sexual dysfunction

Intervention Type OTHER

Sexual dysfunction will be determined with separate scales for women and men

Group of control

Healthy volunteers of the same age and gender as patients

Sexual dysfunction

Intervention Type OTHER

Sexual dysfunction will be determined with separate scales for women and men

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sexual dysfunction

Sexual dysfunction will be determined with separate scales for women and men

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being diagnosed with AS for individuals with AS,
* No additional disease (comorbid and psychiatric disease, hypothyroidism, hypopituitarism, hypogonadism or hyperprolactinemia)
* Having a partner (relationship status in a monogamous sexual relationship),
* Not smoking and drinking,
* Non-AS partner have not been diagnosed with AS and their partner is AS.

Exclusion Criteria

* Overweight or obesity (BMI \<28 kg / m2)
* Having had a pelvic injury, urological or gynecological operation in the last 3 months
* Hypogonadism; penile abnormalities such as hypospadias, congenital curvature or Peyronie's disease with preserved penis stiffness
* Prostatic disorder
* Use of drugs that may affect erectile function (steroids, antihistamines, ß-blockers or SSRIs)
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Antalya Training and Research Hospital

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ayse Ayan

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ayse Ayan, MD

Role: PRINCIPAL_INVESTIGATOR

Antalya Training and Research Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Antalya Tarining and Research Hospital Ethics Commitee

Antalya, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ayse Ayan, MD

Role: CONTACT

+90 545 960 04 78

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Aysel Uysal, MD

Role: primary

+90 242 249 44 00-4217

References

Explore related publications, articles, or registry entries linked to this study.

Liu YF, Dong H, Chen Z, Wang YU, Tu SH. Impact of ankylosing spondylitis on sexual function: A systematic review and meta-analysis. Exp Ther Med. 2015 Apr;9(4):1501-1507. doi: 10.3892/etm.2015.2239. Epub 2015 Jan 29.

Reference Type RESULT
PMID: 25780459 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2016-098

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Yoga for Rheumatoid Arthritis
NCT00349869 COMPLETED NA